Veristat Supports 12% of all FDA NME Approvals in 2018, a Record-Setting Year for FDA Approvals

Veristat Supports 12% of all FDA NME Approvals in 2018, a Record-Setting Year for FDA Approvals

Veristat provided strategic planning as well as statistical analysis and medical writing for 12% of 2018 FDA approvals, including breakthrough oncology products as well as therapies for rare genetic-based disorders and infectious diseases.

Learn More
Best Practices for Navigating a Complex Regulatory Submission

Best Practices for Navigating a Complex Regulatory Submission

By utilizing key submission preparation strategies, you can propel even the most complex marketing applications (NDAs/MAAs) to successful regulatory conclusions.

Learn More
Clarity on FDA's Expectations for Adaptive Design Clinical Trials

Clarity on FDA's Expectations for Adaptive Design Clinical Trials

Adaptive designs can be advantageous for certain clinical trials - understanding the full spectrum of considerations before implementation is important.

Learn More

An Impactful CRO, Committed to Making a Difference.

Helping companies improve and save lives.  Advancing medical innovations through the clinical development & regulatory submission process with a focus on strategy, accuracy, and success.

How Can We Help You Make a Difference?

Contact Us
Learn More

Integrated Clinical and Regulatory Solutions to Ensure Success

Our highly qualified scientific experts help emerging, small and mid-sized biopharmaceuticals  advance through the clinical development process  to bring their therapies to patients who need them.  Explore how.

Explore Veristat

We Value Expertise & Foster Growth

Employees at Veristat handle complex work that is both rewarding and meaningful. Our team members are dedicated partners to internal colleagues and external clients alike.

Our values include:

  • Teamwork - We are all in this together, we help one another whenever and however we can. 
  • Attentiveness - We listen to each other and to our clients. We learn the facts before drawing conclusions.
  • Creativity - We learn from everything we do and are always thinking about how to provide our clients with smarter, faster, and more impactful services.
  • Flexibility - We go the extra mile to help our clients and our colleagues with open minds and new ideas.
  • Thoughtfulness - We think about issues from multiple angles, with a global outlook and natural curiosity.


If this sounds like an environment you would thrive in, then click below to learn more about us.

Explore More


A TRUE Partnership From The Beginning

Since the day Veristat was formed, our approach has focused on partnership.  We aren’t here to complicate your studies, we are here to be a true extension of your team, to build enduring partnerships, to be a trust-worthy teacher and respected team member.

We are here to be TRUE Partners to You

Explore More


Proficiency In Nearly Every Therapeutic Area

Our teams support innovative, life-enhancing, and life-saving therapies that range from novel vaccines for global pandemics to new approaches for treating fungal infections to the latest immunotherapies to eradicate cancer.   We have the right expertise and therapeutic understanding and creative know-how to help you design, build, and run your clinical development program in any therapeutic area.  

Our core therapeutic Centers of Excellence include:  Cancers, Rare Diseases, CNS Disorders, Cardiovascular Disease, Infectious Diseases and more.

Explore More


Explore Your Career with Veristat

View Open Positions

Latest Updates from Veristat

Blog Image_Conference

Outsourcing in Clinical Trials Southeast 2019

Meet Veristat at the upcoming OCT Southeast 2019 event taking place in Durham, NC on March 26-27, 2019.

We provide impactful strategies and solutions to meet your outsourcing needs in order to plan and run your next clinical trial, program or regulatory submission project.  

Blog Image_Antibe2

Veristat Advances Game-Changing Pain and Inflammation Therapy

Veristat continues to support Antibe Therapeutics, a biotech company with a drug platform of game-changing therapeutics in pain and inflammation, as they receive approval to initiate the second part of their phase 2B dose-ranging, efficacy study for ATB-346. 

Office Locations Within Reach

Veristat teams are expanding to ensure clinical development success and maintain local regulatory knowledge.
Contact Us
Request A Proposal